Certara, Inc. stock is up 29.96% since 30 days ago. The next earnings date is Feb 28, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 3 December’s closed higher than November. 0% of analysts rate it a buy.
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. The company also provides related technology- enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.